Neurocrine Biosciences Statistics
Total Valuation
NBIX has a market cap or net worth of $13.63 billion. The enterprise value is $12.93 billion.
| Market Cap | 13.63B |
| Enterprise Value | 12.93B |
Important Dates
The last earnings date was Wednesday, May 1, 2024, before market open.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NBIX has 100.64 million shares outstanding. The number of shares has increased by 6.69% in one year.
| Shares Outstanding | 100.64M |
| Shares Change (YoY) | +6.69% |
| Shares Change (QoQ) | +1.37% |
| Owned by Insiders (%) | 1.01% |
| Owned by Institutions (%) | 96.00% |
| Float | 99.41M |
Valuation Ratios
The trailing PE ratio is 37.10 and the forward PE ratio is 28.58. NBIX's PEG ratio is 0.44.
| PE Ratio | 37.10 |
| Forward PE | 28.58 |
| PS Ratio | 6.88 |
| Forward PS | 5.91 |
| PB Ratio | 5.71 |
| P/FCF Ratio | 22.18 |
| PEG Ratio | 0.44 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.01, with an EV/FCF ratio of 21.04.
| EV / Earnings | 34.97 |
| EV / Sales | 6.52 |
| EV / EBITDA | 26.01 |
| EV / EBIT | 27.25 |
| EV / FCF | 21.04 |
Financial Position
The company has a current ratio of 2.52, with a Debt / Equity ratio of 0.21.
| Current Ratio | 2.52 |
| Quick Ratio | 2.33 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 1.03 |
| Debt / FCF | 0.83 |
| Interest Coverage | 103.15 |
Financial Efficiency
Return on equity (ROE) is 17.50% and return on invested capital (ROIC) is 12.61%.
| Return on Equity (ROE) | 17.50% |
| Return on Assets (ROA) | 12.10% |
| Return on Capital (ROIC) | 12.61% |
| Revenue Per Employee | $1.42M |
| Profits Per Employee | $264,071 |
| Employee Count | 1,400 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.10 |
Taxes
In the past 12 months, NBIX has paid $100.20 million in taxes.
| Income Tax | 100.20M |
| Effective Tax Rate | 21.32% |
Stock Price Statistics
The stock price has increased by +51.25% in the last 52 weeks. The beta is 0.28, so NBIX's price volatility has been lower than the market average.
| Beta (1Y) | 0.28 |
| 52-Week Price Change | +51.25% |
| 50-Day Moving Average | 138.43 |
| 200-Day Moving Average | 126.01 |
| Relative Strength Index (RSI) | 43.07 |
| Average Volume (30 Days) | 830,982 |
Short Selling Information
The latest short interest is 1.86 million, so 1.85% of the outstanding shares have been sold short.
| Short Interest | 1.86M |
| Short Previous Month | 1.83M |
| Short % of Shares Out | 1.85% |
| Short % of Float | 1.87% |
| Short Ratio (days to cover) | 2.40 |
Income Statement
In the last 12 months, NBIX had revenue of $1.98 billion and earned $369.70 million in profits. Earnings per share was $3.65.
| Revenue | 1.98B |
| Gross Profit | 1.94B |
| Operating Income | 464.40M |
| Pretax Income | 469.90M |
| Net Income | 369.70M |
| EBITDA | 497.00M |
| EBIT | 474.50M |
| Earnings Per Share (EPS) | $3.65 |
Balance Sheet
The company has $1.21 billion in cash and $511.90 million in debt, giving a net cash position of $698.70 million or $6.94 per share.
| Cash & Cash Equivalents | 1.21B |
| Total Debt | 511.90M |
| Net Cash | 698.70M |
| Net Cash Per Share | $6.94 |
| Equity / Book Value | 2.39B |
| Book Value Per Share | 23.71 |
| Working Capital | 1.09B |
Cash Flow
In the last 12 months, operating cash flow was $645.40 million and capital expenditures -$31.00 million, giving a free cash flow of $614.40 million.
| Operating Cash Flow | 645.40M |
| Capital Expenditures | -31.00M |
| Free Cash Flow | 614.40M |
| FCF Per Share | $6.16 |
Margins
Gross margin is 98.05%, with operating and profit margins of 23.43% and 18.65%.
| Gross Margin | 98.05% |
| Operating Margin | 23.43% |
| Pretax Margin | 23.71% |
| Profit Margin | 18.65% |
| EBITDA Margin | 25.08% |
| EBIT Margin | 23.94% |
| FCF Margin | 31.00% |
Dividends & Yields
NBIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.69% |
| Shareholder Yield | -6.69% |
| Earnings Yield | 2.71% |
| FCF Yield | 4.51% |
Analyst Forecast
The average price target for NBIX is $153.95, which is 13.69% higher than the current price. The consensus rating is "Buy".
| Price Target | $153.95 |
| Price Target Difference | 13.69% |
| Analyst Consensus | Buy |
| Analyst Count | 23 |
| Revenue Growth Forecast (5Y) | 15.52% |
| EPS Growth Forecast (5Y) | 42.06% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NBIX has an Altman Z-Score of 8.88 and a Piotroski F-Score of 5.
| Altman Z-Score | 8.88 |
| Piotroski F-Score | 5 |